Edition:
United States

Tamara Mathias

Sleep deprivation could be as risky for drivers as alcohol

Oct 08 2018

(Reuters Health) - Drivers who hit the road on less than four hours of sleep are at least as likely to be involved in a crash as drivers who had too much to drink, a U.S. study suggests.

J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion

Oct 04 2018

Arrowhead Pharmaceuticals Inc said on Thursday Johnson & Johnson would develop and market its gene-silencing Hepatitis B treatment and buy a minor stake in a deal that could be potentially worth more than $3.7 billion, sending its shares surging 20 percent.

FDA seizes documents from Juul in latest e-cigarette crackdown

Oct 02 2018

The U.S. Food and Drug Administration said on Tuesday it seized more than a thousand pages of documents from Juul Labs related to the company's sales and marketing practices after a surprise inspection, the latest clampdown on e-cigarette companies. | Video

Pfizer to replace longtime CEO Read with veteran Bourla

Oct 01 2018

Pfizer Inc Chief Executive Officer Ian Read will hand over the reins of the largest U.S. drugmaker to veteran insider Albert Bourla in January, after eight years at the helm, in the backdrop of increased scrutiny over drug pricing.

Merck's Frazier to remain CEO of the U.S. drugmaker beyond 2019

Sep 26 2018

Merck & Co Inc Chief Executive Officer Kenneth Frazier will remain in the role beyond 2019, the drugmaker said on Wednesday, after it scrapped a policy requiring its CEOs to retire at the age of 65.

Boston Scientific's drug-coated stent gets FDA approval

Sep 24 2018

The U.S. Food and Drug Administration on Monday approved Boston Scientific Corp's drug-coated stent Eluvia to treat narrowed arteries in the leg.

One in three gun-owning U.S. veterans don't store weapons safely

Sep 20 2018

(Reuters Health) - A substantial percentage of U.S. military vets store guns loaded and ready to use, according to an American study that could have implications for suicide prevention.

Viking shares surge after fatty liver drug trial

Sep 18 2018

Viking Therapeutics Inc's shares more than doubled in value on Tuesday after promising data from a mid-stage trial of its fatty liver drug were seen as topping that from larger rival Madrigal Pharmaceuticals .

Cancer in parents may affect kids' academic, professional development

Sep 05 2018

Children of cancer patients are at risk of receiving lower grades in school, not being as academically qualified as peers, and earning less as young adults, a Danish study suggests.

World News